Cytek Biosciences, Inc. (CTKB) has 52 open-market insider trades by 13 insiders since 2021. The most active filer is Ming Yan, CTO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Kolchinsky | Dir | — | 1 | $50.1M | 2021-07-27 |
| Rajeev M. Shah | Dir | — | 4 | $29.8M | 2022-03-11 |
| RA Capital Management, L.P. | Dir | — | 1 | $7.4M | 2022-02-16 |
| RA Capital Healthcare Fund LP | Dir10% Owner | — | 1 | $7.2M | 2022-03-15 |
| RA Capital Nexus Fund II, L.P. | Dir | — | 1 | $5.6M | 2022-02-25 |
| Ming Yan | CTO | — | 19 | $4.1M | 2026-08-18 |
| Wenbin Jiang | CEOPres | — | 17 | $3.8M | 2026-08-18 |
| Jack Ball | Dir | — | 2 | $286K | 2026-06-10 |
| Patrik Jeanmonod | CFO | — | 2 | $103K | 2024-03-11 |
| William D. McCombe | CFO | — | 1 | $97K | 2026-08-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William D. McCombe | CFO | Buy | $97K | 2025-06-02 |
| Ming Yan | CTO | Sell | $117K | 2024-04-19 |
| Ming Yan | CTO | Sell | $13K | 2024-04-09 |
| Ming Yan | CTO | Sell | $270K | 2024-03-18 |
| Patrik Jeanmonod | CFO | Sell | $29K | 2023-12-26 |
| Ming Yan | CTO | Sell | $189K | 2023-12-19 |
Companies that share insiders with CTKB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Patrik Jeanmonod | CFO | Sell | $21K | 2023-11-24 |
| Ming Yan | CTO | Sell | $121K | 2023-11-20 |
| Wenbin Jiang | CEO & President | Sell | $87K | 2023-11-07 |
| Patrik Jeanmonod | CFO | Sell | $14K | 2023-10-24 |
| Ming Yan | CTO | Sell | $96K | 2023-10-19 |
| Wenbin Jiang | CEO & President | Sell | $107K | 2023-10-09 |
| Patrik Jeanmonod | CFO | Sell | $19K | 2023-09-25 |
| Ming Yan | CTO | Sell | $130K | 2023-09-19 |
| Wenbin Jiang | CEO & President | Sell | $137K | 2023-09-07 |